Trial | NCT00883155  Report issue

Title

To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions.

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    bupropion ...

  • Study Participants

    36
To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets under Fasting Conditions.
Study Started
Oct 31
1998
Primary Completion
Oct 31
1998
Study Completion
Oct 31
1998
Last Update
Mar 29
2017

Drug Bupropion HCl 100 mg Tablets (Invamed Inc.)

Drug Wellbutrin 100 mg Tablets (Glaxo Wellcome)

2 Active Comparator

Wellbutrin 100 mg Tablets (Glaxo Wellcome)

1 Experimental

Bupropion HCl 100 mg Tablets (Invamed Inc.)

Criteria 

Inclusion Criteria:

No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion Criteria:

Positive test results for HIV or hepatitis B or C.
Treatment for drug or alcohol dependence.
No Results Posted